Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)Recruiting
NCT06825091Phase 3Updated Jun 2, 2026
Sponsor: University Health Network, Toronto
Localized Prostate Cancer · Stereotactic Body Radiotherapy
Canada
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use DisorderRecruiting
NCT07118839Phase 2, Phase 3Updated Jun 2, 2026
Sponsor: VA Office of Research and Development
Post Traumatic Stress Disorder · Alcohol Use Disorder
United States
Home-based Cardiac Rehabilitation in Heart FailureRecruiting
NCT06349941Phase 3Updated Jun 2, 2026
Sponsor: University of Texas Southwestern Medical Center
Heart Failure
United States
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid TumorsRecruiting
NCT07444723Phase 2, Phase 3Updated Jun 2, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary Hyperparathyroidism · Parathyroid Cancer · Multiple Endocrine Neoplasias · Heritable Hyperparathyroidism
United States
Phase 3 Trial of eRapa in Patients With Familial Adenomatous PolyposisRecruiting
NCT06950385Phase 3Updated Jun 2, 2026
Sponsor: Rapamycin Holdings Inc.
Familial Adenomatous Polyposis (FAP)
United States, Denmark, Germany, Italy, Netherlands +2 more
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung CancerRecruiting
NCT07459751Phase 2, Phase 3Updated Jun 1, 2026
Sponsor: Shanghai Henlius Biotech
Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
China
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibRecruiting
NCT03651206Phase 2, Phase 3Updated Jun 1, 2026
Sponsor: ARCAGY/ GINECO GROUP
Ovarian Carcinosarcoma · Endometrial Carcinosarcoma
France, Italy, Spain
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control TrialRecruiting
NCT06200181Phase 3Updated Jun 1, 2026
Sponsor: M.D. Anderson Cancer Center
Misuse, Opioid
United States
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMRecruiting
NCT05271240Phase 3Updated Jun 1, 2026
Sponsor: Northwell Health
Glioblastoma · Glioblastoma Multiforme · Glioma, Malignant · GBM
United States
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana LinfomiRecruiting
NCT05929222Phase 3Updated Jun 1, 2026
Sponsor: Fondazione Italiana Linfomi - ETS
Follicular Lymphoma
Italy
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgANRecruiting
NCT06994845Phase 3Updated Jun 1, 2026
Sponsor: Novartis Pharmaceuticals
Primary Immunoglobulin A Nephropathy (IgAN)
United States, Australia, China, Hong Kong, Israel +2 more
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisRecruiting
NCT07616375Phase 3Updated Jun 1, 2026
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Non-cystic Fibrosis Bronchiectasis
China
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic HepatitisRecruiting
NCT06956482Phase 3Updated Jun 1, 2026
Sponsor: University Hospital, Lille
Alcoholic Hepatitis
France
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]Recruiting
NCT05895786Phase 3Updated Jun 1, 2026
Sponsor: Pfizer
Myositis
United States, Argentina, Bulgaria, China, France +15 more
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)Recruiting
NCT07165951Phase 3Updated May 29, 2026
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Metastatic Pancreatic Ductal Adenocarcinoma
China
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural HematomaRecruiting
NCT05713630Phase 3Updated May 29, 2026
Sponsor: Unity Health Toronto
Subdural Hematoma
Canada
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of AgeRecruiting
NCT06740630Phase 3Updated May 29, 2026
Sponsor: GlaxoSmithKline
Chickenpox
United States, Belgium, Colombia, Czechia, Dominican Republic +6 more
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT05995353Phase 3Updated May 29, 2026
Sponsor: AbbVie
Crohn's Disease
United States, Belgium, Bulgaria, Canada, China +16 more
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary BypassRecruiting
NCT06702553Phase 3Updated May 29, 2026
Sponsor: Xijing Hospital
Nitric Oxide · Cardiac Surgery · Cardiopulmonary Bypass · Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass
United States, China, Russia
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of AgeRecruiting
NCT06806137Phase 3Updated May 29, 2026
Sponsor: GlaxoSmithKline
Chickenpox
Dominican Republic, Honduras
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of AgeRecruiting
NCT06855160Phase 3Updated May 29, 2026
Sponsor: GlaxoSmithKline
Chickenpox
United States, Belgium, Estonia, Greece, Poland +2 more
Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover TrialRecruiting
NCT06903416Phase 2, Phase 3Updated May 29, 2026
Sponsor: University of Alberta
Spinal Cord Injury Cervical
Canada
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaRecruiting
NCT07287644Phase 2, Phase 3Updated May 29, 2026
Sponsor: Bluefin Biomedicine, Inc.
Hidradenitis Suppurativa (HS)
United States, Bulgaria, Canada, Czechia, Germany +2 more
Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast CancerRecruiting
NCT07615751Phase 3Updated May 29, 2026
Sponsor: Fudan University
Breast Cancer
China
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeRecruiting
NCT06693895Phase 3Updated May 29, 2026
Sponsor: GlaxoSmithKline
Chickenpox
United States, Bulgaria, Denmark, Estonia, Hong Kong +3 more

Previous page Next page